← Back to Search

VS LIFU/ VPL LIFU for Alcoholism

N/A
Waitlist Available
Led By Khaled Moussawi, MD, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1. Male or female ≥ 18 years of age.
2. Documentation of an AUD diagnosis per DSM-5 criteria as evidenced by problematic pattern of alcohol use leading to clinically significant impairment or distress, as manifested by at least two of the DSM-5 criteria, occurring within a 12-month period.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 visits over 3 weeks
Awards & highlights

Summary

This study aims to examine the effects of Low-Intensity Focused Ultrasound (LIFU) on brain activity in patients with alcohol use disorder.

Eligible Conditions
  • Alcoholism

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 visits over 3 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 visits over 3 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of LIFU-related adverse events.
Reward network activity in response to alcohol cues.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VS LIFU/ VPL LIFUExperimental Treatment1 Intervention
Participants will be assigned to receive VS LIFU during the first LIFU treatment session.
Group II: VPL LIFU/VS LIFUActive Control1 Intervention
Participants will be assigned to receive VPL LIFU during the first LIFU treatment session.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,538 Previous Clinical Trials
15,262,462 Total Patients Enrolled
21 Trials studying Alcoholism
3,723 Patients Enrolled for Alcoholism
Khaled Moussawi, MD, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
7 Total Patients Enrolled
1 Trials studying Alcoholism
2 Patients Enrolled for Alcoholism
~17 spots leftby Sep 2027